Unmet Need for Oral Corticosteroids Use and Exacerbations of Asthma in Primary Care in Taiwan
Open Access
- 14 December 2022
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 10 (12) , 3253
Abstract
Patients with asthma are treated in primary healthcare facilities (PHCFs) in Taiwan, where the asthma control status associated with acute exacerbation (AE) and use of oral corticosteroids (OCS) and short-acting β2-agonist (SABA) inhalers remains unclear. A cross-sectional, close-ended, face-to-face questionnaire survey invited board-certified physicians who treat adult asthma patients in PHCFs. The contents of the questionnaire included three parts: rescue OCS to treat AE, regular OCS for asthma control, and AE-related adverse outcomes. There were 445 out of 500 physicians who completed the questionnaire, with 61% of them being non-pulmonologists. A substantial proportion of asthma patients needed rescue OCS or regular OCS each month, or ≥3 canisters of SABA inhalers per year. Approximately 86% of physicians reported their patients with ≥2 AE-related unscheduled visits to clinics or emergency departments in the past year. A total of 41% of physicians reported their patients receiving intubation or intensive care in the past year. A total of 92% of physicians prescribed rescue OCS ≤ 40 mg/day. A total of 92% of physicians prescribed rescue OCS for a duration of ≤7 days for AEs. A total of 85% of physicians prescribed regular OCS ≤ 10 mg/day for asthma control. This is the first study to present the perceptions of asthma-treating physicians on the use of OCS in PHCFs. In summary, 31% of physicians reported ≥ 6% of their patients needed OCS for asthma control and 41% of physicians reported their patients with adverse outcomes in the past year. Thus, the need to improve asthma control in Taiwan is suggested by our study results.Keywords
Funding Information
- Taipei Veterans General Hospital (V109C-190 and V110C-115)
This publication has 27 references indexed in Scilit:
- Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma RegistryThorax, 2016
- Analysis of Prescription Pattern and Guideline Adherence in the Management of Asthma Among Medical Institutions and Physician Specialties in Taiwan Between 2000 and 2010Clinical Therapeutics, 2015
- A qualitative study of the impact of severe asthma and its treatment showing that treatment burden is neglected in existing asthma assessment scalesQuality of Life Research, 2014
- International ERS/ATS guidelines on definition, evaluation and treatment of severe asthmaEuropean Respiratory Journal, 2013
- Utilization of Mechanical Ventilation for Asthma Exacerbations: Analysis of a National DatabaseRespiratory Care, 2013
- Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthmaJournal of Allergy and Clinical Immunology, 2012
- Subspecialty Differences in Asthma Characteristics and ManagementMayo Clinic Proceedings, 2008
- Rates and characteristics of intensive care unit admissions and intubations among asthma-related hospitalizationsAnnals of Allergy, Asthma & Immunology, 2004
- Exacerbations of Asthma: A Descriptive Study of 425 Severe ExacerbationsAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997